Dr. Majhail is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2410 Patterson St
Ste 500
Nashville, TN 37203Phone+1 615-342-7440
Education & Training
- University of MinnesotaFellowship, Hematology and Medical Oncology, 2004 - 2007
- Cleveland Clinic FoundationResidency, Internal Medicine, 2001 - 2004
- Government Medical College ChandigrahClass of 1997
Certifications & Licensure
- TN State Medical License 2021 - 2026
- NV State Medical License 2023 - 2025
- OH State Medical License 2000 - 2022
- FL State Medical License 2016 - 2020
- MN State Medical License 2006 - 2014
- American Board of Internal Medicine Hematology
Clinical Trials
- The Financial Impact of Allogeneic Stem Cell Transplantation on Patient and Family Start of enrollment: 2009 Mar 01
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
- Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation Start of enrollment: 2012 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsTherapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.Brian T. Hill, Lisa Rybicki, Theresa A. Urban, Mariana Lucena, Deepa Jagadeesh
Biology of Blood and Marrow Transplantation. 2020-02-01 - 62 citationsPractice variation in physician referral for allogeneic hematopoietic cell transplantationJoseph Pidala, Benjamin M. Craig, Stephanie J. Lee, Navneet S. Majhail, Gwendolyn P. Quinn
Bone Marrow Transplantation. 2013-01-01 - 37 citationsInferior Access to Allogeneic Transplant in Disadvantaged Populations: A Center for International Blood and Marrow Transplant Research AnalysisKristjan Paulson, Ruta Brazauskas, Nandita Khera, Naya He, Navneet S. Majhail
Biology of Blood and Marrow Transplantation. 2019-10-01
Journal Articles
- Effect of Bone Marrow CD34+Cells and T-cell Subsets on Clinical Outcomes After Myeloablative Allogeneic Hematopoietic Cell TransplantationDeepa Jagadeesh, Matt Kalaycio, Brian Bolwell, Betty K Hamilton, Brian Hill, Brad Pohlman, Robert Dean, Navneet S Majhail, Sagar S Patel, Rabi Hanna, Aaron T Gerds, Ro..., Nature
Abstracts/Posters
- Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoie...Navneet S. Majhail, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat AnalysisNavneet S. Majhail, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Inotuzumab Ozogamicin Post-Transplant for Acute Lymphocytic LeukemiaNavneet S. Majhail, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- How to Set up a Health Services and Outcomes Research Program61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Career-Development Lunch Sessions: Adult Clinical Malignant Hematology/BMT60th American Society of Hematology Annual Meeting - 12/1/2018
- Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus o...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Authored Content
- Standardization of Outpatient Care After CAR-T Therapy Across a Large Cell Therapy Network- Through Technology and Decentralized Virtual Nurses: Preliminary ResultsDecember 2023
Press Mentions
- Navneet Majhail Named Deputy Physician-in-Chief of Blood Cancers at Sarah CannonJune 25th, 2021
- A Deep Dive into HLA Typing for Unrelated Donor Hematopoietic Cell TransplantationMay 20th, 2021
- Piner Man Is Cleveland Clinic's First MS Patient for Special TreatmentFebruary 28th, 2021
Professional Memberships
- Member
- Member
- American Society for Transplantation and Cellular TherapyMember
External Links
- Sarah Cannonhttps://sarahcannon.com/
- Twitter (@BldCancerDoc)https://twitter.com/BldCancerDoc
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: